Stockscreener 앱 받기
9.45
6.55%
-0.66
Ginkgo Bioworks Holdings Inc 주식(DNA)의 최신 뉴스
Ginkgo Bioworks : Q1 2026 Results Presentation - marketscreener.com
DNAGinkgo Bioworks Holdings Inc Options - Finviz
Ginkgo Bioworks reports Q1 revenue decline, reaffirms cash burn - Investing.com
Earnings call transcript: Ginkgo Bioworks Q1 2026 sees revenue drop, restructuring efforts noted - Investing.com
ETFs Investing in Ginkgo Bioworks Holdings, Inc. Class A Stocks - TradingView
Most Volatile Stocks in the US (July 2026) - Investing.com
Ginkgo Bioworks Holdings Inc Warrant 2021-01.08.26 on Ginkgo Bioworks -A Financial Disclosures & SEC Filings - TradingView
Ginkgo Bioworks (DNA) Holds Near $10.21 as Stock Consolidates in Tight RangeIron Condor Alert - dars.gov.et
Ginkgo Bioworks Holdings, Inc.(NYSE:DNA) dropped from Russell 3000E Growth Benchmark - marketscreener.com
Ginkgo Bioworks Holdings, Inc.(NYSE: DNA) dropped from Russell 3000 Growth Benchmark - marketscreener.com
Ginkgo Bioworks Holdings, Inc.(NYSE:DNA) dropped from Russell Microcap Growth Benchmark Index - marketscreener.com
Palantir's Bold Biosecurity Opportunity Could Be Bigger Than Investors Think - The Motley Fool
Ginkgo Bioworks (DNA) Q1 2026 Earnings: EPS Misses Estimates, Stock Surges Over 7%Buyback Announcement Report - dars.gov.et
Enterprise value to revenue forward of Ginkgo Bioworks Holdings, Inc. – NYSE:DNA - TradingView
Price to earnings forward of Ginkgo Bioworks Holdings, Inc. – NYSE:DNA - TradingView
Enterprise value to EBIT forward of Ginkgo Bioworks Holdings, Inc. – NYSE:DNA - TradingView
Enterprise value to EBITDA forward of Ginkgo Bioworks Holdings, Inc. – NYSE:DNA - TradingView
Price to sales forward of Ginkgo Bioworks Holdings, Inc. – NYSE:DNA - TradingView
Ginkgo Bioworks Holdings, Inc. Class A Actuals & Estimates (NYSE:DNA) - TradingView
9L40 Forecast — Price Target — Prediction for 2027 - TradingView
Price to sales forward of Ginkgo Bioworks Holdings Inc. – OTC:DNABW - TradingView
Price to earnings forward of Ginkgo Bioworks Holdings Inc. – OTC:DNABW - TradingView
Enterprise value to EBITDA forward of Ginkgo Bioworks Holdings Inc. – OTC:DNABW - TradingView
Price to book forward of Ginkgo Bioworks Holdings Inc. – OTC:DNABW - TradingView
DNA Forecast — Price Target — Prediction for 2027 - TradingView
Ginkgo Bioworks Holdings Inc (DNA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Ginkgo Bioworks Holdings Inc (DNA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Ginkgo Bioworks Holdings Inc (DNA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
The Technical Signals Behind (DNA) That Institutions Follow - Stock Traders Daily
DNA Technical Analysis & Stock Price Forecast - Intellectia AI
Ginkgo Bioworks Holdings Inc (DNA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Ginkgo Bioworks Holdings Inc (DNA) Institutional Confidence - TradingKey
Ginkgo Bioworks Holdings Inc (DNA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Ginkgo Bioworks Holdings Inc - TradingKey
Ginkgo Bioworks Holdings Inc (DNA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Ginkgo Bioworks Holdings Inc (DNA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Ginkgo Bioworks (DNA) director Henry Christian O receives 25,000 RSU equity grant - Stock Titan
Director Ross Fubini receives 25,000 RSUs at Ginkgo Bioworks (NYSE: DNA) - Stock Titan
Director at Ginkgo Bioworks (NYSE: DNA) granted 25,000 RSUs - Stock Titan
Ginkgo Bioworks (DNA) director Harry Sloan awarded 25,000 RSUs - Stock Titan
Ginkgo Bioworks Holdings, Inc. Files Form 8-K With SEC for June 2026 – Key Submission Details and Company Information 17 – Minichart - Minichart
Ginkgo Bioworks Shareholders Back Board, Governance Structure - The Globe and Mail
Ginkgo Bioworks (NYSE: DNA) shareholders approve directors, Deloitte and executive pay - Stock Titan
Austin Che (DNA) files Form 144 showing sales totaling tens of thousands of Class A shares - Stock Titan
Precision Trading with Ginkgo Bioworks Holdings Inc. Class A (DNA) Risk Zones - Stock Traders Daily
Ginkgo Bioworks Holdings, Inc. - MLQ.ai
Top Ginkgo Bioworks (DNA) Competitors 2026 - MarketBeat
Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of Ginkgo Bioworks Holdings, Inc. of Deadline in Securities Fraud Class Action Lawsuit and Encourages Investors with Significant Losses to Contact the Firm - TMX Newsfile
Technical Reactions to DNA Trends in Macro Strategies - Stock Traders Daily
Ginkgo Bioworks (NYSE: DNA) insider logs RSU vesting and small tax-related share sale - Stock Titan
Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Launch ADME-One: a High-Throughput ADME Platform That Brings Pharmacokinetic Projection Earlier in Drug Discovery - Investing News Network
Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Launch ADME-One™: a High-Throughput ADME Platform That Brings Pharmacokinetic Projection Earlier in Drug Discovery - marketscreener.com
Ginkgo Bioworks, Tangible Scientific, And Inductive Bio Launch ADME-One High-Throughput ADME Platform - marketscreener.com
New AI lab service aims for fewer dead ends in drug discovery - Stock Titan
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Dips While Market Gains: Key Facts - MSN
Ginkgo Bioworks Holdings (DNA) Price Target Decreased by 11.11% to 10.88 - MSN
Steve Coen (DNA) files Form 144 to sell 307 Class A shares - Stock Titan
Ginkgo Bioworks Holdings Inc (DNA): What’s the Future of Autonomous Lab? - Yahoo Finance
DNA Technical Analysis | Trend, Signals & Chart Patterns | GINKGO BIOWORKS HOLDINGS INC (NYSE:DNA) - ChartMill
Trading the Move, Not the Narrative: (DNA) Edition - Stock Traders Daily
Ginkgo Bioworks Announces Presentations at the Upcoming American - GuruFocus
Viking Global (DNA) reports 3,577,128 shares, removes retired reporting person - Stock Titan
1.60%
3.59%
자본화:
|
볼륨(24시간):